STOCK TITAN

Barfresh Q3 going-concern warning: Cash at $247K

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Barfresh Food Group Inc. (BRFH) reported third-quarter 2026 revenue of $5.778 million, up 37% from $4.231 million a year earlier; raw and processed milk contributed $2.529 million. Frozen beverages and food revenue fell 23% to $3.249 million. Gross profit was $1.208 million versus $1.552 million. Operating income was $120,000, compared with a $260,000 loss. Interest expense was $344,000, and net loss was $224,000 versus $290,000.

For the first nine months, revenue rose 83% to $16.117 million, while net loss widened to $2.746 million from $1.931 million. Operating activities used $3.624 million in cash, and cash was $247,000 at September 30, 2026. Net current liabilities were $1.529 million, including $1.919 million in construction payables and excluding $499,000 in disputed accounts payable.

Management disclosed substantial doubt about BRFH’s ability to continue as a going concern: planned mortgage and equipment financing for the New Facility was unsigned and not considered probable of effective implementation. Remaining expansion costs were estimated at $5.1 million net of USDA grant funding. Disclosure controls were ineffective, with a material weakness tied primarily to inadequate segregation of duties in information technology control activities.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue rose 37% to $5.778 million year over year.

Negative

  • Major pointSubstantial doubt about continuing as a going concern remained at September 30, 2026.
  • Major pointDisclosure controls were ineffective at September 30, 2026, with a material weakness.
  • Moderate pointNine-month net loss increased to $2.746 million from $1.931 million.
  • Moderate pointOperating cash used was $3.624 million, versus $2.173 million.
Third-quarter revenue $5.778 million Three months ended September 30, 2026; $4.231 million in 2025, up 37%.
Third-quarter net loss $224,000 Three months ended September 30, 2026; compared with $290,000 in 2025.
Nine-month revenue $16.117 million Nine months ended September 30, 2026; $8.786 million in 2025, up 83%.
Nine-month net loss $2.746 million Nine months ended September 30, 2026; compared with $1.931 million in 2025.
Cash used in operating activities $3.624 million Nine months ended September 30, 2026; compared with $2.173 million in 2025.
Cash $247,000 As of September 30, 2026.
Net current liabilities $1.529 million As of September 30, 2026; includes $1.919 million in construction payables and excludes $499,000 in disputed accounts payable.
Remaining New Facility expansion costs Approximately $5.1 million As of September 30, 2026, net of USDA grant funding.
substantial doubt financial
"substantial doubt about its ability to continue as a going concern"
material weakness financial
"a material weakness due to the control environment"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
convertible notes financial
"issuance of $7,528,000 of convertible notes in March 2026"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
performance obligation financial
"Identify the performance obligation in the contract"
A performance obligation is a specific promise in a contract to deliver a good or provide a service to a customer, and it is the unit companies use to decide when and how much revenue to record. Think of it like checklist items in a service agreement: each item completed can trigger part of the payment to be recognized as revenue. Investors care because how obligations are identified and satisfied changes the timing and amount of reported revenue and profits, affecting comparisons and valuation.
volume-weighted average price financial
"10-day volume-weighted average price"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
receivables-based line of credit financial
"raised its receivables-based line of credit"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did BRFH report in Q3 2026?

BRFH reported revenue of $5.778 million for the three months ended September 30, 2026, up 37% from $4.231 million in the year-earlier quarter. Raw and processed milk sales contributed $2.529 million.

Why does BRFH report substantial doubt about its ability to continue as a going concern?

At September 30, 2026, BRFH had $247,000 in cash, and planned mortgage and equipment financing commitments had not been signed. Management said its plans could not be considered probable of effective implementation until definitive agreements were executed, so substantial doubt had not been alleviated.

When must BRFH complete the USDA-funded phases and spend the grant?

The USDA extended the deadline for completing all funded phases and spending the grant funds to April 30, 2027. Remaining New Facility expansion costs were estimated at approximately $5.1 million net of USDA grant funding. The company said construction obligations could increase to $7.5 million if the funds were not used by the extended deadline.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0001487197 0001487197 2026-01-01 2026-09-30 0001487197 2026-11-16 0001487197 2026-09-30 0001487197 2025-12-31 0001487197 2026-07-01 2026-09-30 0001487197 2025-07-01 2025-09-30 0001487197 2025-01-01 2025-09-30 0001487197 2024-12-31 0001487197 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2026-07-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2025-07-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2026-01-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2025-01-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2026-07-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2025-07-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2026-01-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2025-01-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2026-07-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2025-07-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2026-01-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2025-01-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerCMember 2026-07-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerCMember 2025-07-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerCMember 2026-01-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerCMember 2025-01-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerDMember 2026-07-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerDMember 2025-07-01 2025-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerDMember 2026-01-01 2026-09-30 0001487197 BRFH:PurchaseMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerDMember 2025-01-01 2025-09-30 0001487197 us-gaap:LandMember 2026-09-30 0001487197 us-gaap:LandMember 2025-12-31 0001487197 us-gaap:BuildingMember 2026-09-30 0001487197 us-gaap:BuildingMember 2025-12-31 0001487197 BRFH:ManufacturingEquipmentMember 2026-09-30 0001487197 BRFH:ManufacturingEquipmentMember 2025-12-31 0001487197 BRFH:CustomerEquipmentMember 2026-09-30 0001487197 BRFH:CustomerEquipmentMember 2025-12-31 0001487197 us-gaap:ConstructionInProgressMember 2026-09-30 0001487197 us-gaap:ConstructionInProgressMember 2025-12-31 0001487197 BRFH:FinancingLeasesMember 2026-07-01 2026-09-30 0001487197 BRFH:FinancingLeasesMember 2026-01-01 2026-09-30 0001487197 BRFH:FinancingLeasesMember 2025-07-01 2025-09-30 0001487197 BRFH:FinancingLeasesMember 2025-01-01 2025-09-30 0001487197 BRFH:FinancingLeasesMember BRFH:ManufacturingEquipmentMember 2026-09-30 0001487197 BRFH:FinancingLeasesMember BRFH:ManufacturingEquipmentMember 2025-12-31 0001487197 BRFH:FinancingLeasesMember BRFH:CustomerEquipmentMember 2026-09-30 0001487197 BRFH:FinancingLeasesMember BRFH:CustomerEquipmentMember 2025-12-31 0001487197 BRFH:FinancingLeasesMember us-gaap:ConstructionInProgressMember 2026-09-30 0001487197 BRFH:FinancingLeasesMember us-gaap:ConstructionInProgressMember 2025-12-31 0001487197 BRFH:FinancingLeasesMember 2026-09-30 0001487197 BRFH:FinancingLeasesMember 2025-12-31 0001487197 2024-08-31 0001487197 2025-10-31 0001487197 2024-08-01 2024-08-31 0001487197 BRFH:ExistingLoanMember 2026-02-10 2026-02-10 0001487197 BRFH:ManagerNoteMember 2026-02-10 2026-02-10 0001487197 BRFH:ManagerNoteMember us-gaap:CommonStockMember 2026-02-10 2026-02-10 0001487197 2026-03-05 2026-03-05 0001487197 us-gaap:ConvertibleNotesPayableMember 2026-03-23 0001487197 us-gaap:RelatedPartyMember 2026-03-23 0001487197 us-gaap:RelatedPartyMember 2026-03-05 2026-03-23 0001487197 us-gaap:ConvertibleNotesPayableMember 2026-03-05 2026-03-23 0001487197 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2026-03-23 0001487197 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2026-03-05 2026-03-23 0001487197 us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2026-03-23 0001487197 BRFH:ArpsDairyIncMember 2026-09-30 0001487197 BRFH:ArpsDairyIncMember 2025-12-31 0001487197 BRFH:ArpsDairyIncMember 2026-01-01 2026-09-30 0001487197 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2026-01-01 2026-09-30 0001487197 us-gaap:FairValueInputsLevel3Member BRFH:CallMember 2026-01-01 2026-09-30 0001487197 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2026-09-30 0001487197 us-gaap:FairValueInputsLevel3Member BRFH:CallMember 2026-09-30 0001487197 2023-12-31 0001487197 us-gaap:AccountsPayableMember 2026-09-30 0001487197 2022-01-01 2022-12-31 0001487197 2021-01-01 2021-12-31 0001487197 us-gaap:RelatedPartyMember 2022-07-31 0001487197 us-gaap:CommonStockMember 2024-12-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001487197 us-gaap:RetainedEarningsMember 2024-12-31 0001487197 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001487197 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001487197 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001487197 us-gaap:CommonStockMember 2025-09-30 0001487197 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001487197 us-gaap:RetainedEarningsMember 2025-09-30 0001487197 us-gaap:CommonStockMember 2025-12-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001487197 us-gaap:RetainedEarningsMember 2025-12-31 0001487197 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001487197 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001487197 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001487197 us-gaap:CommonStockMember 2026-09-30 0001487197 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001487197 us-gaap:RetainedEarningsMember 2026-09-30 0001487197 us-gaap:WarrantMember 2026-09-30 0001487197 2025-01-01 2025-12-31 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2025-12-31 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2026-01-01 2026-09-30 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2026-09-30 0001487197 us-gaap:PerformanceSharesMember 2025-12-31 0001487197 us-gaap:PerformanceSharesMember 2026-01-01 2026-09-30 0001487197 us-gaap:PerformanceSharesMember 2026-09-30 0001487197 us-gaap:FoodAndBeverageMember 2026-07-01 2026-09-30 0001487197 us-gaap:FoodAndBeverageMember 2025-07-01 2025-09-30 0001487197 us-gaap:FoodAndBeverageMember 2026-01-01 2026-09-30 0001487197 us-gaap:FoodAndBeverageMember 2025-01-01 2025-09-30 0001487197 BRFH:RawAndProcessedMilkMember 2026-07-01 2026-09-30 0001487197 BRFH:RawAndProcessedMilkMember 2025-07-01 2025-09-30 0001487197 BRFH:RawAndProcessedMilkMember 2026-01-01 2026-09-30 0001487197 BRFH:RawAndProcessedMilkMember 2025-01-01 2025-09-30 0001487197 2026-02-28 0001487197 2026-03-31 0001487197 2026-03-01 2026-03-31 0001487197 us-gaap:LandAndBuildingMember 2026-03-31 0001487197 srt:MaximumMember 2026-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft BRFH:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________________ to ___________________

 

Commission File Number: 001-41228

 

BARFRESH FOOD GROUP INC.

(Exact name of registrant as specified in its charter)

 

Delaware   27-1994406

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

12100 Wilshire Blvd., 8th Floor,

Los Angeles, California

  90025
(Address of principal executive offices)   (Zip Code)

 

310-598-7113

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.000001 par value   BRFH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by the check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 16,526,777 shares as of November 16, 2026.

 

 

 

 

 

 

TABLE OF CONTENTS

 

   

Page

Number

PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements. 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 18
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 23
Item 4. Controls and Procedures. 23
     
PART II – OTHER INFORMATION 24
     
Item 1. Legal Proceedings. 24
Item 1A. Risk Factors. 24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 24
Item 3. Defaults Upon Senior Securities. 24
Item 4. Mine Safety Disclosures. 24
Item 5. Other Information. 24
Item 6. Exhibits. 24
     

SIGNATURES

25

 

2

 

 

Item 1. Financial Statements.

 

Barfresh Food Group Inc.

Condensed Consolidated Balance Sheets

 

   September, 30   December 31, 
   2026   2025 
   (unaudited)   (audited) 
Assets          
Current assets:          
Cash  $247,000   $325,000 
Trade accounts receivable, net   2,126,000    1,957,000 
Other receivables   32,000    99,000 
Inventory, net   2,127,000    1,665,000 
Prepaid expenses and other current assets   286,000    182,000 
Total current assets   4,818,000    4,228,000 
Property, plant and equipment, net of depreciation   8,996,000    8,297,000 
Intangible assets, net of amortization   125,000    125,000 
Other non-current assets   123,000    180,000 
Total assets  $14,062,000   $12,830,000 
Liabilities and Stockholders’ Equity          
Current liabilities:          
Line of credit  $987,000   $1,124,000 
Accounts payable - trade   2,240,000    3,086,000 
Accounts payable - construction in progress   1,919,000    2,433,000 
Disputed co-manufacturer accounts payable (Note 5)   499,000    499,000 
Accrued expenses   355,000    388,000 
Accrued payroll and employee related expenses   121,000    173,000 
Financing agreements - current   284,000    296,000 
Notes payable   441,000    3,031,000 
Total current liabilities   6,846,000    11,030,000 
Financing agreements   474,000    470,000 
Convertible notes   7,064,000    - 
Total liabilities   14,384,000    11,500,000 
Commitments and contingencies   -    - 
Stockholders’ (deficit) equity:          
Preferred stock, $0.000001 par value, 400,000 shares authorized, none issued or outstanding   -    - 
Common stock, $0.000001 par value; 35,000,000 shares authorized; and 16,308,172 and 15,969,281 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively   -    - 
Additional paid in capital   68,739,000    67,645,000 
Accumulated deficit   (69,061,000)   (66,315,000)
Total stockholders’ (deficit) equity   (322,000)   1,330,000 
Total liabilities and stockholders’ (deficit) equity  $14,062,000   $12,830,000 

 

See the accompanying notes to the condensed consolidated financial statements

 

3

 

 

Barfresh Food Group Inc.

Condensed Consolidated Statements of Operations

For the three and nine months ended September 30, 2026 and 2025

(Unaudited)

 

   2026   2025   2026   2025 
   For the three months ended September 30,   For the 9 months ended September 30, 
   2026   2025   2026   2025 
Revenue  $5,778,000   $4,231,000   $16,117,000   $8,786,000 
Cost of revenue   4,570,000    2,679,000    14,026,000    5,828,000 
Gross profit   1,208,000    1,552,000    2,091,000    2,958,000 
Operating expenses:                    
Selling, marketing and distribution   757,000    941,000    2,016,000    2,399,000 
General and administrative   329,000    844,000    1,877,000    2,264,000 
Depreciation and amortization   2,000    27,000    31,000    161,000 
Total operating expenses   1,088,000    1,812,000    3,924,000    4,824,000 
Profit (Loss) from operations   120,000    (260,000)   (1,833,000)   (1,866,000)
                     
Interest expense   344,000    30,000    913,000    65,000 
Net loss  $(224,000)  $(290,000)  $(2,746,000)  $(1,931,000)
Per share information - basic and fully diluted:                    
Weighted average shares outstanding   16,308,000    15,940,000    16,168,000    15,756,000 
Net loss per share  $(0.01)  $(0.02)  $(0.17)  $(0.12)

 

See the accompanying notes to the condensed consolidated financial statements

 

4

 

 

Barfresh Food Group Inc.

Consolidated Statements of Cash Flows

For the nine months ended September 30, 2026 and 2025

(Unaudited)

 

   2026   2025 
Net loss  $(2,746,000)  $(1,931,000)
Adjustments to reconcile net loss to net cash used in operating activities          
Stock-based compensation   54,000    461,000 
Depreciation and amortization   227,000    185,000 
Amortization of financing discounts   196,000    (12,000)
Changes in assets and liabilities          
Accounts receivable   (169,000)   (1,660,000)
Other receivables   67,000    (7,000)
Inventories   (462,000)   426,000 
Prepaid expenses and other assets   (47,000)   (269,000)
Accounts payable – trade   (846,000)   529,000 
Accrued expenses   102,000    105,000 
Net cash used in operating activities   (3,624,000)   (2,173,000)
           
Investing activities          
Purchase of property and equipment   (1,280,000)   (42,000)
Net cash used in investing activities   (1,280,000)   (42,000)
           
Financing activities          
Borrowings under line of credit   11,227,000    4,389,000 
Repayment of line of credit   (11,382,000)   (3,250,000)
Issuance of convertible debt and warrants, net of $154,000 issuance cost   7,374,000    - 
Repayment of mortgage note   (2,170,000)   - 
Financing agreement payments   (168,000)   (81,000)
Issuance of common stock, net of $26,000 issuance cost   -    2,974,000 
Shares repurchased for income tax withholding under stock compensation program   (55,000)   (161,000)
Net cash provided by financing activities   4,826,000    3,871,000 
           
Net (decrease) increase in cash   (78,000)   1,656,000 
Cash, beginning of period   325,000    235,000 
Cash, end of period  $247,000   $1,891,000 
           
Cash paid for interest  $307,000   $53,000 
Non-cash financing and investing activities:          
Conversion of notes payable to equity  $420,000   $454,000 
Financed acquisition of long-term assets  $160,000   $- 
Issuance of warrants to brokers in convertible debt and warrant offering  $4,000   $- 
Accrued Interest satisfied thru issuance of common stock  $187,000   $- 

 

See the accompanying notes to the condensed consolidated financial statements

 

5

 

 

Barfresh Food Group Inc.

Notes to Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

 

Note 1. Description of the Business, Basis of Presentation, and Summary of Significant Accounting Policies

 

Barfresh Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February 25, 2010 in the State of Delaware. The Company is engaged in the manufacturing and distribution of frozen beverages and food, including ready-to-drink and ready-to-blend smoothies, shakes, frappes and ice cream mix, and raw and processed milk.

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements are unaudited, except for the condensed balance sheet as of December 31, 2025. These unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on April 15, 2026. In management’s opinion, the unaudited interim condensed consolidated financial statements reflect all adjustments, which are of a normal and recurring nature, that are necessary for a fair presentation of financial results for the interim periods presented. Operating results for any quarter are not necessarily indicative of the results for the full fiscal year.

 

Principles of Consolidation

 

The consolidated financial statements include the financial statements of the Company and our wholly-owned subsidiaries, Barfresh Inc., Barfresh Corporation Inc. (formerly known as Smoothie, Inc.), and Arps Dairy, Inc. All inter-company balances and transactions among the companies have been eliminated upon consolidation.

 

Use of Estimates

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.

 

Vendor Concentrations

 

Since the Acquisition, Arps Dairy has commenced production of virtually all of the Company’s legacy product lines. Historically, the Company was exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract manufacturers.

 

A comparison of production of legacy product lines by source is summarized in the table below:

 

   2026   2025   2026   2025 
   3 months ended September 30,   9 months ended September 30, 
   2026   2025   2026   2025 
Owned production facility   91%   -%   84%   -%
Co-manufactured:                    
Manufacturer A   1%   36%   4%   44%
Manufacturer B   -%   40%   -%   41%
Manufacturer C   8%   10%   9%   10%
Manufacturer D   -%   14%   3%   5%
Concentration risk, percentage, Total   100%   100%   100%   100%

 

6

 

 

Manufacturer A gave notice that it would not renew the contract with the Company when it concluded in February 2026. Additionally, in December 2025, Manufacturer B discontinued manufacturing our products. The commencement of production at Arps Dairy is a significant step towards mitigating the impact of these contract losses, and the potential adverse effect on the Company’s business, financial condition and results of operations.

 

Summary of Significant Accounting Policies

 

There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026 that have had a material impact on our condensed consolidated financial statements and related notes.

 

Financial Instruments

 

The Company’s financial instruments consist of cash, accounts receivable, accounts payable, the line of credit, financing agreements, notes payable and convertible notes. The carrying value of the Company’s financial instruments approximates their fair value.

 

Accounts Receivable and Allowances

 

Accounts Receivable are recorded and carried at the original invoiced amount less allowances for credits and for any potential uncollectible amounts due to credit losses. We make estimates of the expected credit and collectability trends for the allowance for credit losses based on our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect our ability to collect from our customers. Expected credit losses are recorded as general and administrative expenses on our condensed consolidated statements of operations. As of September 30, 2026 and December 31, 2025, there was no allowance for credit losses. There was no credit loss expense for the three and nine months ended September 30, 2026 and 2025.

 

Government Grant

 

The Company has been awarded a $2,470,000 government grant (the “USDA Grant”) to fund 50% of equipment and installation costs for the New Facility. Funding is dependent on meeting specific criteria in the grant agreement, including completion of all funded phases, and may require repayment if costs are disallowed due to partial completion. The USDA has extended the deadline for completion of all funded phases from December 31, 2026 to April 30, 2027, by which date the grant funds must have been spent. The Company expects to early adopt the Financial Accounting Standards Board’s Accounting Standards Update 2025-10, Government Grants. Grant proceeds will reduce the value of the assets acquired and the resulting depreciation expense over the estimated useful lives of the assets acquired.

 

Derivative Liability

 

The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC 815, Derivatives and Hedging. The Company determined that its convertible instruments issued in 2026 did not include embedded derivatives that required bifurcation due to the scope exception in ASC 815.

 

7

 

 

Revenue Recognition

 

In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps:

 

  1) Identify the contract with a customer
     
    A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers.
     
  2) Identify the performance obligation in the contract
     
    Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer.
     
  3) Determine the transaction price
     
    The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically include rebates or discounts, are estimated utilizing the most likely amount method. Provisions for refunds are generally provided for in the period the related sales are recorded, based on management’s assessment of historical and projected trends.
     
  4) Allocate the transaction price to performance obligations in the contract
     
    Since the Company’s contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation.
     
  5) Recognize revenue when or as the Company satisfies a performance obligation
     
    The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction in sales at the time the sale is recognized. Shipping and handling costs are treated as fulfilment costs and presented in distribution, selling and administrative costs.

 

Storage and Shipping Costs

 

Storage and outbound freight costs are included in selling, marketing and distribution expenses. For the three months ending September 30, 2026, and 2025, storage and outbound freight totaled approximately $548,000 and $491,000, respectively. For the nine months ended September 30, 2026, and 2025, storage and outbound freight totaled approximately $1,297,000 and $1,157,000, respectively.

 

Research and Development

 

Expenditures on research activities relating to product development and improvement are charged to expenses as incurred. The Company incurred approximately $30,000 and $33,000 in research and development expenses for the three months ending September 30, 2026, and 2025, respectively. For the nine months ending September 30, 2026, and 2025, research and development expense totaled approximately $91,000 and $82,000, respectively.

 

Loss Per Share

 

For the three and nine months ended September 30, 2026, and 2025, common stock equivalents have not been included in the calculation of net loss per share as their effect is anti-dilutive because of losses incurred.

 

8

 

 

Recent Pronouncements

 

From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.

 

Note 2. Inventory

 

Inventory consists of the following:

 

   September 30,   December 31, 
   2026   2025 
Raw materials and packaging  $1,147,000   $684,000 
Finished goods   980,000    981,000 
Inventory, net  $2,127,000   $1,665,000 

 

Note 3. Property Plant and Equipment

 

Property and equipment, net consist of the following:

  

   September 30,   December, 31 
   2026   2025 
Land  $357,000   $357,000 
Building   1,834,000    1,834,000 
Manufacturing equipment   3,353,000    2,335,000 
Customer equipment   1,393,000    1,426,000 
Construction in progress   5,047,000    5,139,000 
Property and equipment, gross   11,984,000    11,091,000 
Less: accumulated depreciation   (2,988,000)   (2,794,000)
Property and equipment, net of depreciation  $8,996,000   $8,297,000 

 

Depreciation expense related to these assets was approximately $80,000 and $24,000 for the three months ended September 30, 2026, and 2025, respectively, and $227,000 and $132,000 for the nine months ended September 30, 2026, and 2025, respectively. Depreciation expense in cost of revenue was $78,000 and $9,000 for the three months ended September 30, 2026, and 2025, respectively, and $195,000 and $25,000 for the nine months ended September 30, 2026, and 2025, respectively.

 

Assets subject to financing leases consist of the following:

 

   September 30,   December, 31 
   2026   2025 
Manufacturing equipment  $560,000   $106,000 
Customer equipment   33,000    33,000 
Construction in progress   560,000    704,000 
Property and equipment, gross   1,153,000    843,000 
Less: accumulated depreciation   (45,000)   (15,000)
Property and equipment, net of depreciation  $1,108,000   $828,000 

 

Depreciation expense related to leased assets amounted to $17,000 and $30,000 for the three-month and nine-month periods ending September 30, 2026, respectively. No depreciation expense related to leased assets was recorded for the three or nine-month periods ending September 30, 2025, as all leased assets were included in construction in progress at that time.

 

9

 

 

Note 4. Debt

 

Line of Credit

 

In August 2024, the Company secured receivables financing of $1,500,000 (the “Barfresh Facility”) and amended the facility in September 2025 to increase the available financing to $2,500,000. In October 2025, the Company secured receivables financing of $1,250,000 for Arps Dairy (together with the Barfresh Facility, the “Credit Facilities”).

 

Under the Credit Facilities, the Company may borrow up to 90% of eligible customer account balances. Amounts outstanding bear interest at a rate based on the prime rate plus collateral fees and are secured by accounts receivable and inventory. The weighted average rate was 8.0% and 8.4% as of September 30, 2026, and December 31, 2025, respectively. The Credit Facilities expire in September and October 2026, and renew automatically, unless notice is given or received.

 

As of September 30, 2026, there was $987,000 drawn under the Credit Facilities, and $2,763,000 was available to borrow, subject to available collateral. There was no unamortized deferred financing discount as of September 30, 2026.

 

Financing Agreements

 

The Company has entered into financing agreements to purchase equipment and software as a service, with a weighted average imputed or stated interest of 21%. Amounts due under the agreement are due over a weighted average period of 28 months, with maturities as follows as of September 30, 2026:

 

      
2026 (3 months)  $125,000 
2027   430,000 
2028   118,000 
2029   235,000 
2030   49,000 
Total payments due   957,000 
Less: interest   (199,000)
Financing agreements   758,000 
Less: current portion   (284,000)
Financing agreements  $474,000 

 

Notes Payable

 

   September 30,   December 31, 
   2026   2025 
Managers note  $41,000   $61,000 
Advances from Arps Dairy former stockholders   400,000    800,000 
Mortgage Note payable to bank in monthly installments of $22,000 including interest at 6.85% with a balloon payment due January 1, 2026; secured by real property and personal guarantees of Arp’s former stockholders.   -    2,170,000 
Total payments due   441,000    3,031,000 
Less: current portion   (441,000)   (3,031,000)
Long-term portion  $-   $- 

 

On February 10, 2026, the Company elected to convert $400,000 of the Advances from Arps Dairy former stockholders and $20,000 of the manager note into 129,032 and 6,540 of the Company’s common stock, respectively. See Note 6.

 

10

 

 

On March 5, 2026, the maturity date of the New Advances was extended to the earlier of October 1, 2026, or the receipt of financing secured by real estate owned by the Company. Additionally, the amendments provide that holder may elect to have interest paid in cash or shares valued at a 10% discount to the volume-weighted average price of the common stock over the ten trading days immediately preceding the payment. The Company is in negotiations for an additional extension.

 

The Mortgage Note was repaid in March 2026 with the proceeds of the convertible note and warrant issuance.

 

Convertible Notes and Warrants

 

Beginning on March 5, 2026, and through March 23, 2026, the Company obtained subscriptions for unsecured senior convertible promissory notes in the aggregate amount of $7,528,000 (the “Notes”) from accredited investors, including $230,000 (3.1%) sold to related parties. Net proceeds amounted to $7,374,000, after cash issuance costs of $154,000. The Notes bear interest at 10% per annum for the first 12 months of the 24-month term, regardless of earlier payment or conversion (the “Minimum Interest”), and are mandatorily convertible as to principal and interest into shares of the Company’s common stock at any time prior to maturity at the conversion price of $2.90 per share (the “Conversion Price”), if the common stock of the Company trades at $4.35 per share (150% of the Conversion Price) for 20 out of the preceding 30 consecutive trading days. The holders of the Notes have the option on up to 10 occasions to convert all or any portion of the principal and interest into shares of the Company’s common stock at the Conversion Price. The Company may prepay the Notes at any time prior to maturity, subject to payment of the Minimum Interest, any other accrued but unpaid interest, and a prepayment penalty of 5% if the amount of the Note principal that is prepaid does not exceed 50% or a prepayment penalty of 10% if the amount of the Note principal that is prepaid exceeds 50%. Interest is to be paid quarterly in arrears beginning April 1, 2026, and can be paid in either cash or shares of the Company’s common stock at the election of the Company. If paid in stock, the shares must be registered and valued at a 10% discount to the 10-day volume-weighted average price.

 

Purchasers of the Notes were issued 2,352,500 detachable warrants to purchase common stock (the “Warrants’) at a price of $3.20 per share (the “Exercise Price”) for a 4-year term from date of issuance in an amount equal to 100% of their investment amounts. The Company may call the Warrants (the “Call”) if the common stock of the Company trades at or above $4.80 per share (150% of the Exercise Price) for 20 out of the preceding 30 consecutive trading days. Additionally, 22,655 broker warrants were issued at an exercise price of $3.48 per share for a 3-year term, expiring March 10, 2029.

 

Should the Company sell any of its securities in a capital-raising transaction at a price lower than the Conversion Price while any Notes are outstanding, the Conversion Price will adjust to that lower price. The Warrant Exercise Price will be adjusted to a 10% premium to the new Note conversion price.

 

The warrants are legally detachable, separately exercise and accounted for as equity. Additionally, the conversion feature meets the scope exception of ASC 815 and was not bifurcated from the debt host contract.

 

At issuance, the Company allocated $484,000 of the net proceeds to the warrants using the relative fair value method. The warrants were valued using the Black-Scholes option pricing model, based on the difference between two options, representing the value of the warrant excluding the value derived from appreciation of the Company’s common stock in excess of the strike price of the Call, with the following Level 3 inputs:

Schedule of Black-scholes Option Pricing Model 

   Warrant   Call 
Risk-free interest rate   3.5%   3.5%
Expected volatility   90.0%   90.0%
Expected term (years)   4    4 
Expected dividends  $-   $- 
Stock price  $2.76   $2.76 
Exercise price  $3.20   $4.80 

 

The allocation resulted in a corresponding debt discount of $642,000, inclusive of $148,000 in transaction costs, which is being amortized to interest expense over the term of the note using the effective interest method, resulting in $78,000 and $178,000 in interest expense for the three and nine months ended September 30, 2026, respectively.

 

11

 

 

Note 5. Commitments and Contingencies

 

Lease Commitments, Construction and Demolition

 

The Company leased headquarters office space under a non-cancelable operating lease which expired on March 31, 2023, and had been extended multiple times, most recently through March 31, 2026. The lease was not extended on March 31, 2026, and new commitments for headquarters facilities are leased on a month-to-month basis at a nominal cost. The Company’s periodic lease cost was none and approximately $20,000 for the three-month periods ending September 30, 2026, and 2025, respectively, and $23,000 and $65,000 for the nine-month periods ending September 30, 2026 and 2025, respectively.

 

During 2023, the Arps Dairy sold its manufacturing facility (the “Existing Facility”) and purchased a different facility, executing both transactions with the same counterparty. Following the exchange, Arps Dairy commenced to expand the acquired property to provide 44,000 square feet of production and office space (the “New Facility”). Arps Dairy continues to operate at the Existing Facility under a leasing arrangement. The initial lease term was 18 months, and the lease was classified as an operating lease. Additionally, the counterparty leases space at the New Facility. Neither party pays rent for the space that it occupies.

 

In connection with the Acquisition, the lease on the Existing Facility was extended until September 30, 2026, to permit the completion of the New Facility. The Company is subject to penalties of $1,000 per day if it has not vacated and demolished the Existing Facility by September 30, 2026, subject to limitations if delays are caused by a force majeure event or construction-related delays that are beyond the Company’s reasonable control. The terms of the lease and the demolition agreement were extended without penalty from September 30, 2026 to June 30, 2027 due to delays beyond the Company’s reasonable control.

 

As of September 30, 2026, the approximate remaining costs of the New Facility expansion is approximately $5,100,000, net of USDA Grant funding. The Company, including Arps Dairy prior to the Acquisition, has incurred $4,997,000, including $1,919,000 in Accounts Payable – Construction in Progress.

 

Other than amounts included in Accounts Payable – Construction in Progress, there are no firm commitments for capital expenditures. However, the Company would face significant uncertainty about its ability to supply products if it is unable to complete the New Facility, which would in turn have a material impact on its financial position, operating results, and cash flows. Expected capital expenditures to complete the New Facility expansion, including settlement of Accounts Payable – Construction in Progress, amount to $5,100,000, net of USDA Grant funding (the “Construction Obligations”). The USDA Grant is subject to uncertainty and possible repayment associated with the requirement to complete all funded phases of the project by December 31, 2026. The Company has applied for and obtained an extension of the grant to April 30, 2027 to use the necessary funds. This uncertainty could increase the Construction Obligation to $7,500,000 if the funds are not used by April 30, 2027. The Company expects to finance the Construction Obligations from mortgage and equipment loans. There can be no assurance that sources of financing will be available to satisfy the Construction Obligations.

 

Accounts Payable – Construction in Progress is primarily owed to the construction contractor for work performed in the first half of 2025. In conjunction with the Acquisition, the contractor agreed to forebear from filing a mechanics lien against the building through December 2, 2025. Additionally, the agreement with the contractor stipulates that if any portion of the balance remains outstanding after December 31, 2025, it will accrue interest at 8% per annum from day sixty-one until repayment is received, subject to rate adjustment for scope modifications.

 

The Company is liable for the demolition of the Existing Facility, once it has vacated the premises. The Company has been awarded a $50,000 grant from the city of Defiance to pay for the demolition, which expires on December 31, 2026. No liability is currently recorded for the demolition as management believes the grant is sufficient to cover the liability and the Company is in discussions for an extension to match that of the property owner’s extension of June 30, 2027.

 

12

 

 

Legal Proceedings

 

Schreiber Dispute

 

The Company’s products had been produced to their specifications through several contract manufacturers. One of the Company’s contract manufacturers (the “Manufacturer”) provided approximately 52% and 42% of the Company’s products in the years ended December 31, 2022, and 2021, respectively, under a Supply Agreement with an initial term through September 2025.

 

Over the course of 2022, the Company experienced numerous quality issues with the case packaging utilized by the Manufacturer. In addition, in July of 2022, the Company began receiving customer complaints about the texture of the Company’s smoothie products produced by the Manufacturer. In response, the Company withdrew product from the market and destroyed on-hand inventory, withholding $499,000 in payments due to the Manufacturer.

 

The Company attempted to resolve the issues based on the contractual procedures described in the Supply Agreement. However, on November 4, 2022, in response to a formal proposal of alternate resolutions, the Company received notification from the Manufacturer that it was denying any responsibility for the defective manufacture of the product. In response, on November 10, 2022, the Company filed a complaint in the United States District Court for the Central District of California, Western Division (the “Complaint”), claiming that the Manufacturer had not met its obligations under the Supply Agreement, and seeking economic damages. In response, the Manufacturer terminated the Supply Agreement. On January 20, 2023, the Company filed a voluntary dismissal of the Complaint which allowed the parties to reach a potential resolution outside of the court system. However, as the parties were once again unable to come to an agreement, the Company re-filed the Complaint in California State Court in August 2023 and continues to progress through the court system.

 

In May 2024, the Company entered into a non-recourse litigation financing arrangement which is expected to be adequate to pursue the Complaint to conclusion.

 

In 2025, the California State Court heard on the merits of fraud claims included in the Complaint and determined that there was sufficient evidence to allow the claims to be heard. A trial date has been set for April 2027.

 

Due to the uncertainties surrounding the claim, the Company cannot predict either the outcome or a range of reasonably possible recoveries that could result from its actions against the Manufacturer, and no gain contingencies have been recorded. The disruption in its supply resulting from the dispute has and will continue to adversely impact the Company’s results of operations and cash flow until a suitable resolution is reached or new sources of reliable supply at sufficient volume can be identified and developed, the timing of which is uncertain. The Company has mitigated the impact of the supply disruption with the introduction of its single-serve smoothie cartons; however, the product format has not been accepted by some customers or as a substitute for the bottle product in all use cases. Additionally, the Company acquired Arps Dairy in the fourth quarter of 2025 and is ramping up production of its products at Arps.

 

Other legal matters

 

From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe a material unfavorable outcome to be remote.

 

13

 

 

Note 6. Stockholders’ (Deficit) Equity

 

The following are changes in stockholders’ (deficit) equity for the nine months ending September 30, 2026, and 2025:

 

   Shares   Amount   Capital   (Deficit)   Total 
   Common Stock  

Additional

paid in

   Accumulated     
   Shares   Amount   Capital   (Deficit)   Total 
Balance December 31, 2024   14,746,172   $       -   $64,199,000   $(63,621,000)  $578,000 
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding   141,296    -    (161,000)   -    (161,000)
Equity-based compensation expense   -    -    461,000    -    461,000 
Registered issuance of common stock   1,052,793    -    2,974,000    -    2,974,000 
Net loss   -    -    -    (1,931,000)   (1,931,000)
Balance September 30, 2025   15,940,261   $-   $67,473,000   $(65,552,000)  $1,921,000 

 

   Common Stock   Additional paid in   Accumulated     
   Shares   Amount   Capital   (Deficit)   Total 
Balance December 31, 2025   15,969,281   $       -   $67,645,000   $(66,315,000)  $1,330,000 
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding   103,307    -    (55,000)   -    (55,000)
Equity-based compensation expense   -    -    54,000    -    54,000 
Shares issued in settlement of former Arps shareholder and manager notes   135,572    -    420,000    -    420,000 
Issuance of detachable warrants   -    -    488,000         488,000 
Shares issued for convertible note interest   100,012    -    187,000         187,000 
Net loss   -    -    -    (2,746,000)   (2,746,000)
Balance September 30, 2026   16,308,172   $-   $68,739,000   $(69,061,000)  $(322,000)

 

Warrants

 

In association with the issuance of convertible notes (Note 4), 2,375,155 warrants were issued at a weighted average exercise price of $3.20 per share and remain outstanding as of September 30, 2026. The weighted average remaining term of the warrants is 3.4 years as of September 30, 2026.

 

Equity Incentive Plan

 

As of September 30, 2026, the Company has $124,000 of total unrecognized share-based compensation expense related to unvested options, stock awards and stock units, which is expected to be recognized over the remaining weighted average period of 2.2 years.

 

14

 

 

Stock Options

 

The following is a summary of stock option activity for the nine months ended September 30, 2026:

 

   Number of Options  

Weighted

average exercise

price per share

  

Remaining

term in years

 
Outstanding on December 31, 2025   763,002   $4.60    5.3 
Granted   29,030   $2.62    8.0 
Forfeited   (136,831)  $2.41      
Outstanding on September 30, 2026   655,201   $4.97    4.8 
Exercisable, September 30, 2026   616,932   $5.06    3.9 

 

The fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following:

 

   2026 
Expected term (in years)   8.0 
Expected volatility   99.8%
Risk-free interest rate   4.2%
Expected dividends  $- 
Weighted average grant date fair value per share  $2.37 

 

Restricted Stock

 

The following is a summary of restricted stock award and restricted stock unit activity for the nine months ended September 30, 2026:

 

   Number of shares  

Weighted

average grant

date fair value

 
Unvested at December 31, 2025   148,554   $2.75 
Granted   24,251   $2.41 
Vested   (67,622)  $2.49 
Forfeited   (66,667)  $2.66 
Unvested at Sept 30, 2026   38,516   $3.14 

 

Performance Share Units

 

From 2023 to 2025, the Company issued performance share units (“PSUs”) that represented shares potentially issuable based upon Company and individual performance in the years of issuance.

 

The following table summarizes the activity for the Company’s unvested PSUs for the nine months ended September 30, 2026:

 

   Number of shares   Weighted
average grant
date fair value
 
Unvested at December 31, 2025   66,743   $2.70 
Vested   (55,211)  $2.63 
Unvested September 30, 2026   11,532   $1.20 

 

15

 

 

Note 7. Income Taxes

 

ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all the deferred tax assets will not be recognized. Accordingly, at this time, the Company has placed a valuation allowance on all tax assets. As of September 30, 2026, the estimated effective tax rate for 2026 was zero.

 

There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2019 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of operations.

 

For the three- and nine-months ending September 30, 2026, and 2025, the Company did not incur any interest and penalties associated with tax positions. As of September 30, 2026, the Company did not have any significant unrecognized uncertain tax positions.

 

Note 8. Business Combination

 

On October 3, 2025, the Company acquired all of the outstanding stock of Arps Dairy, a dairy processing company, in a stock purchase accounted for as a business combination (the “Acquisition”). Arps results of operations have been included in the consolidated statement of operations since October 4, 2025. The following unaudited pro forma information presents the consolidated results of operations as if the acquisition had occurred on January 1, 2025:

 

   2026   2025   2026   2025 
  

For the three months ended

September 30,

  

For the nine months ended

September 30,

 
   2026   2025   2026   2025 
Pro forma revenue  $5,778,000   $8,457,000   $16,117,000   $21,981,000 
Pro forma net loss  $(224,000)  $(465,000)  $(2,746,000)  $(2,931,000)
Pro forma net loss per share, basic and fully diluted  $(0.01)  $(0.03)  $(0.17)  $(0.19)

 

This pro forma data is presented for informational purposes only and does not purport to be indicative of the results of future operations or of the results that would have occurred had the acquisition taken place in the periods noted above. Pro forma net loss for the three months ended September 30, 2025 excludes $214,000 of acquisition costs, which are reflected in the nine months ended September 30, 2025 as if the acquisition had occurred on January 1, 2025.

 

Note 9. Business Segments

 

As a result of the Acquisition, the Company operates in two business segments. The Chief Executive Officer is the chief operating decision maker (“CODM”) who assesses performance and allocates resources based on actual and projected operating results. The CODM reviews revenue and gross profit in evaluating the efficiency of strategies within each segment, ensuring that financial and operational resources are optimized and aligned with the Company’s overall strategic objectives. The tables below present selected segment data:

 

   2026   2025   2026   2025 
   3 months ended Sept 30,   9 months ended Sept 30, 
   2026   2025   2026   2025 
Revenue                    
Frozen beverages and food  $3,249,000   $4,231,000   $8,079,000   $8,786,000 
Raw and processed milk   2,529,000    -    8,038,000    - 
Revenue   5,778,000    4,231,000    16,117,000    8,786,000 
Gross profit                    
Frozen beverages and food   1,109,000    1,552,000    1,805,000    2,958,000 
Raw and processed milk   99,000    -    286,000    - 
Gross (loss) profit   1,208,000    1,552,000    2,091,000    2,958,000 
Unallocated:                    
Total operating expenses   (1,088,000)   (1,812,000)   (3,924,000)   (4,824,000)
                     
Interest expense   (344,000)   (30,000)   (913,000)   (65,000)
Net loss  $(224,000)  $(290,000)  $(2,746,000)  $(1,931,000)

 

16

 

 

Note 10. Liquidity

 

During the nine months ending September 30, 2026, the Company used cash for operations of $3,624,000. As of September 30, 2026, the Company had $247,000 cash and net current assets of $390,000, exclusive of disputed co-manufacturer accounts payable (Note 5) and accounts payable - construction in progress that the Company anticipates settling with a new mortgage note on unencumbered real estate that it owns.

 

The Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully in Note 5, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability to procure certain products necessary to achieve our growth projections and in elevated legal costs that were incurred before the Company obtained non-recourse litigation financing in 2025. The Acquisition is expected to alleviate the supply constraints. However, bring-up costs and lower than anticipated productivity at the Existing Facility have contributed to further losses in 2026.

 

The Company increased its receivables-based line of credit in September 2025 to $2,500,000. In October 2025, Arps Dairy secured a receivables-based line of credit of $1,250,000.

 

In February 2026, $420,000 of notes payable were converted to equity in accordance with the terms of the note agreements.

 

In March 2026, the Company raised $7,528,000 through the sale of convertible promissory notes with a two-year term. The proceeds were used to retire the $2,170,000 Mortgage Note, and pay $532,000 of construction payables, with the balance used to fund working capital. The Company plans to complete construction of the New Facility and pursue long-term real estate and equipment lease financing for the remaining Construction Obligations.

 

Management’s plans to address these conditions include completing the New Facility and financing the remaining Construction Obligations through a package comprising a new mortgage on the Company’s unencumbered real estate, equipment financing and the $2,470,000 USDA grant. The USDA grant has been approved, and the USDA has extended the date by which the funded phases must be completed, and the grant funds spent, to April 30, 2027. The Company’s real estate is owned free and clear, with no mortgage outstanding; at 80% of the approximately $6,000,000 post completion appraised value of the land and building, a mortgage of up to $4,800,000 would be supported, compared to the approximately $4,200,000 mortgage contemplated by management’s plans. The Company is in discussions with three banks regarding the financing package, one of which has expressed strong interest. In addition, the date by which the Company must vacate and demolish the Existing Facility has been extended to June 30, 2027, and the Company has made significant progress in improving production at the Arps facility during 2026, with gross margin of 20.9% in the third quarter.

 

The Company’s financial position at September 30, 2026, and its historical results raise substantial doubt about its ability to continue as a going concern. Management believes that the steps necessary to address these conditions are in place or well advanced, and that its plans, once implemented, would improve the Company’s liquidity and mitigate these conditions. However, the mortgage and equipment financing commitments have not yet been signed, and, until definitive agreements have been executed, those plans cannot be considered probable of being effectively implemented. Accordingly, substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. If the anticipated financing is unavailable, the Company will be required to pursue other options, including reducing its operating expenses.

 

17

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion should be read in conjunction with the financial information included elsewhere in this Quarterly Report on Form 10-Q (this “Report”), including our unaudited condensed consolidated financial statements and the related notes and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026, and other reports that we file with the SEC from time to time.

 

References in this Quarterly Report on Form 10-Q to “us”, “we”, “our” and similar terms refer to Barfresh Food Group Inc.

 

Cautionary Note Regarding Forward-Looking Statements

 

This discussion includes forward-looking statements, as that term is defined in the federal securities laws, based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations, and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. Words such as “anticipate”, “estimate”, “plan”, “continuing”, “ongoing”, “expect”, “believe”, “intend”, “may”, “will”, “should”, “could” and similar expressions are used to identify forward-looking statements.

 

We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

 

Critical Accounting Policies

 

Our consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Results of Operations

 

Results of Operation for the Three Months Ended September 30, 2026 as Compared to the Three Months Ended September 30, 2025

 

Revenue and cost of revenue

 

Revenue increased $1,547,000, or 37%, to $5,778,000 in 2026 as compared to $4,231,000 in 2025. Raw and processed milk sales from Arps Dairy contributed $2,529,000 to revenue. Revenue in the frozen beverages and food segment decreased $982,000, or 23%, to $3,249,000 due to lost menu placements from prior period caused by the Company’s inability to supply a sufficient amount of product. This is in the process of being corrected through the acquisition of Arps Dairy, which gives us the expanded capacity we have sought over the past three years, necessary to service our customer base and expand our sales reach.

 

Cost of revenue increased $1,891,000, or 71%, to $4,570,000 in 2026 as compared to $2,679,000 in 2025. Cost of revenue increased at a significantly higher rate compared to revenue due to the inclusion of the raw and processed milk operations after the Acquisition. Products in this segment are generally commodities with commensurate margins, but provide a strategic milk supply to the business and contribute to fixed overhead costs. Cost of revenue in the frozen beverages and food segment decreased 20%, consistent with lower segment revenue.

 

Our gross profit was $1,208,000 (21%) for 2026 and $1,552,000 (37%) for 2025.

 

18

 

 

Gross profit from frozen beverages and food was $1,109,000 (34%) in 2026 compared to $1,552,000 (37%) in 2025. The decrease is due to high start-up costs and lower than anticipated productivity at the Existing Facility.

 

Gross profit from raw and processed milk was $99,000 (4%) in 2026.

 

Selling, marketing and distribution expense

 

  

3 months ended

September 30, 2026

  

3 months ended

September 30, 2025

   Change   Percent 
Sales and marketing  $209,000   $450,000   $(241,000)   -54%
Storage and outbound freight   548,000    491,000    57,000    12%
   $757,000   $941,000   $(184,000)   -20%

 

Selling, marketing and distribution expense decreased approximately $184,000 (20%) from approximately $941,000 in 2025 to $757,000 in 2026.

 

Sales and marketing expense decreased approximately $241,000 (54%) from approximately $450,000 in 2025 to $209,000 in 2026. The decrease is a result of lower personnel costs as we rely more heavily on our broker network. Additionally, equipment maintenance expense for machines provided to our customers for use with our bulk products decreased, as single serve products have become more prominent in the school setting, and travel, sample and trade show expenses decreased.

 

Storage and outbound freight expense increased approximately $57,000 (12%) from approximately $491,000 in 2025 to $548,000 in 2026, primarily due to costs associated with the delivery of processed milk at Arps Dairy, and higher revenue and finished goods inventory of legacy Barfresh products.

 

General and administrative expense

 

  

3 months ended

September 30, 2026

  

3 months ended

September 30, 2025

   Change   Percent 
Personnel costs  $325,000   $271,000   $54,000    20%
Stock-based compensation   (201,000)   163,000    (364,000)   -223%
Legal, professional and consulting fees   29,000    42,000    (12,000)   -29%
Research and development   30,000    33,000    (3,000)   -9%
Other general and administrative expenses   146,000    121,000    25,000    21%
Business acquisition expense   -    214,000    (214,000)   -100%
   $329,000   $844,000   $(514,000)   -61%

 

General and administrative expenses decreased approximately $514,000 (61%) from approximately $843,000 in 2025 to $329,000 in 2026.

 

Personnel cost represents the cost of employees including salaries, bonuses, employee benefits and employment taxes. Personnel cost increased by approximately $54,000 (20%) from approximately $271,000 in 2025 to $325,000 in 2026 due to the addition of headcount associated with Arps Dairy.

 

Stock-based compensation decreased by approximately $364,000 from expense of $163,000 in 2025 to a benefit of $201,000 in 2026 as a result of the reversal of previously recognized expense on unvested awards forfeited by employees who departed the Company.

 

19

 

 

Legal, professional and consulting fees decreased by approximately $12,000 (29%) from $41,000 in 2025 to $29,000 in 2026 primarily due to lower accounting fees.

 

Other general and administrative expenses increased by approximately $25,000 (21%) from $121,000 in 2025 to $146,000 in 2026 due to increased recruiting and information technology expense, partially offset by lower rent.

 

Interest Expense

 

Interest expense was $344,000 in 2026 compared to $30,000 in 2025. The increase of $314,000 is primarily a result of the issuance of $7,528,000 of convertible notes in March 2026, including amortization of the related debt discount, as well as borrowings under our lines of credit and lease financing related to the purchase of equipment.

 

Net loss

 

We had net losses of approximately $224,000 and $290,000 for the three-month periods ending September 30, 2026 and 2025, respectively. The decrease in net loss of approximately $66,000 was primarily due to an improvement of $380,000 from a loss from operations of $260,000 in 2025 to income from operations of $120,000 in 2026, partially offset by an increase of $314,000 in interest expense.

 

Results of Operation for the Nine Months Ended September 30, 2026 as Compared to the Nine Months Ended September 30, 2025

 

Revenue and cost of revenue

 

Revenue increased $7,331,000, or 83%, to $16,117,000 in 2026 as compared to $8,786,000 in 2025. Raw and processed milk sales from Arps Dairy contributed $8,038,000 to revenue. Revenue in the frozen beverages and food segment decreased $707,000, or 8%, to $8,079,000.

 

Cost of revenue increased $8,198,000, or 141%, to $14,026,000 in 2026 as compared to $5,828,000 in 2025. Cost of revenue increased at a higher rate compared to revenue as low margin milk processing revenue made up 50% of the revenue mix. Additionally, start-up costs and low productivity significantly impacted the cost of legacy Barfresh products that were produced at the Existing Facility.

 

Our gross profit was $2,091,000 (13%) and $2,958,000 (34%) for 2026 and 2025, respectively.

 

Gross profit from frozen beverages and food was $1,805,000 (22%) and $2,958,000 (34%) in 2026 and 2025, respectively. The decrease is due to high start-up costs and lower than anticipated productivity at the Existing Facility. Gross profit from raw and processed milk was $286,000 (4%) in 2026.

 

Selling, marketing and distribution expense

 

  

9 months ended

September 30, 2026

  

9 months ended

September 30, 2025

   Change   Percent 
Sales and marketing  $719,000   $1,242,000   $(523,000)   -42%
Storage and outbound freight   1,297,000    1,157,000    140,000    12%
   $2,016,000   $2,399,000   $(383,000)   -16%

 

Selling, marketing and distribution expense decreased approximately $383,000 (16%) from approximately $2,399,000 in 2025 to $2,016,000 in 2026.

 

Sales and marketing expense decreased approximately $523,000 (42%) from approximately $1,242,000 in 2025 to $719,000 in 2026. The decrease is a result of lower personnel costs as we rely more heavily on our broker network. Additionally, equipment maintenance expense for machines provided to our customers for use with our bulk products decreased, as single serve products have become more prominent in the school setting. Finally, sample expense decreased due to non-recurring sample costs associated with the 2025 launch of our Pop & Go product.

 

20

 

 

Storage and outbound freight expense increased approximately $140,000 (12%) from approximately $1,157,000 in 2025 to $1,297,000 in 2026, primarily due to costs associated with the delivery of processed milk at Arps Dairy, and higher revenue and finished goods inventory of legacy Barfresh products.

 

General and administrative expense

  

9 months ended

September 30, 2026

  

9 months ended

September 30, 2025

   Change   Percent 
Personnel costs  $1,020,000   $936,000   $84,000    9%
Stock based compensation   54,000    461,000    (407,000)   -88%
Legal, professional and consulting fees   201,000    143,000    58,000    41%
Research and development   91,000    82,000    9,000    11%
Other general and administrative expenses   461,000    374,000    87,000    23%
Business acquisition expense   50,000    268,000    (218,000)   -81%
   $1,877,000   $2,264,000   $(387,000)   -17%

 

General and administrative expenses decreased approximately $387,000 (17%) from approximately $2,264,000 in 2025 to $1,877,000 in 2026.

 

Personnel cost increased by approximately $84,000 (9%) from approximately $936,000 in 2025 to $1,020,000 in 2026 due to the addition of headcount associated with Arps Dairy.

 

Stock-based compensation decreased by approximately $407,000 from $461,000 in 2025 to $54,000 in 2026 as a result of the reversal of previously recognized expense on unvested awards forfeited by employees who departed the Company, and lower expected attainment under our performance stock unit program.

 

Legal, professional and consulting fees increased by approximately $58,000 (41%) from $143,000 in 2025 to $201,000 in 2026 due to audit costs associated with the expanded scope of work resulting from the Acquisition, and temporary consultants associated with the integration of Arps Dairy.

 

Other general and administrative expenses increased by approximately $87,000 (23%) from $374,000 in 2025 to $461,000 in 2026 due to increased information technology, recruiting and insurance expense associated with Arps Dairy.

 

Business acquisition and integration expense decreased by approximately $218,000 from $268,000 in 2025, which consisted primarily of costs associated with the acquisition of Arps Dairy, to $50,000 in 2026, which consisted of integration costs.

 

Interest Expense

 

Interest expense was $913,000 in 2026 compared to $65,000 in 2025. The increase of $848,000 is a result of the issuance of $7,528,000 of convertible notes in March 2026, including amortization of the related debt discount, mortgage debt related to the Acquisition that was repaid in March 2026, and borrowings under our lines of credit and lease financing related to the purchase of equipment.

 

Net loss

 

We had net losses of approximately $2,746,000 and $1,931,000 for the nine-month periods ending September 30, 2026 and 2025, respectively. The increase in net loss of approximately $815,000 was primarily due to an increase of $848,000 in interest expense, partially offset by a decrease in loss from operations of $33,000.

 

21

 

 

Liquidity and Capital Resources

 

On February 5, 2025, we entered into securities purchase agreements with several investors, pursuant to which the Company sold an aggregate of 1,052,793 shares of common stock at a price of $2.85 per share in a registered direct offering, raising $2,974,000.

 

Our continuing dispute with the Manufacturer and the resulting loss of product supply in 2022 negatively impacted our financial position, results of operations and cash flow. Subsequently, we contracted with a co-manufacturer for additional smoothie bottle manufacturing capacity. While expanded capacity became available from manufacturer C in the fourth quarter of 2024, we were notified in 2025 that manufacturers A and B elected to discontinue production of smoothie bottles and smoothie cartons in January 2026 and December 2025, respectively. The Acquisition was undertaken to resolve constrained capacity experienced since 2022 under the co-manufacturing business model.

 

In order to consummate the Acquisition, we paid $1,223,000, net of cash acquired, to purchase 100% of Arps Dairy stock. Additionally, we incurred $518,000 in acquisition costs in 2025. In order to finance the Acquisition, we increased our receivables-based line of credit in September 2025 to $2,500,000. As a result of the Acquisition, $5,251,000 of mortgage debt, construction related payables and advances from former shareholders payable by Arps Dairy became short-term financial commitments of the Company. The Acquisition was structured to allow us to take control of Arps Dairy manufacturing operations ahead of completing all necessary long-term financing activities.

 

Following the Acquisition, Arps Dairy secured a receivables-based line of credit of $1,250,000.

 

We acquired $888,000 of equipment through leasing transactions in 2025 and the first nine months of 2026. In December 2025, we were granted $2,470,000 to fund up to 50% of the cost of new equipment purchases and installation for the New Facility.

 

In February 2026, $400,000 of Arps selling shareholder advances were converted into shares of our common stock.

 

In March 2026, we raised $7,528,000 through the sale of convertible promissory notes. The proceeds were used to retire $2,170,000 in mortgage debt and certain construction payables.

 

During the nine months ending September 30, 2026, we used $3,624,000 in operations. Our net loss used $2,746,000, while changes in current assets and liabilities used $1,719,000, primarily because of settlements of amounts due to co-manufacturers who discontinued providing product in December 2025 and January 2026 and increases in inventory and prepaid expenses, partially offset by an increase in other current liabilities.

 

As of September 30, 2026, we had net current liabilities of $1,529,000, including $1,919,000 of construction payables, compared with net current liabilities of $6,303,000 on December 31, 2025. Disputed accounts payable due to the Manufacturer of $499,000 are excluded from both September 30, 2026 and December 31, 2025 amounts.

 

Our operations to date have been financed by the sale of securities, the issuance of convertible and short-term debt and equipment leasing. Our liquidity needs will depend on careful management of the construction of the New Facility, as well as how quickly we are able to profitably ramp up sales, achieve manufacturing cost synergies anticipated as a result of the Acquisition, control and reduce variable operating expenses, and control fixed overhead expense. The proceeds from the sale of convertible promissory notes in March 2026 are not sufficient to carry out our current plan of operations, which includes the investment needed to complete the New Facility expansion as described in Note 5 of the accompanying unaudited financial statements. The $2,470,000 grant received in December 2025 is subject to uncertainty associated with the requirement to complete all funded phases of the project by December 31, 2026; however the Company has submitted and the USDA has approved an application for extension until April 30, 2027. This uncertainty could increase the Construction Obligation to $7,500,000 if the funds are not spent by April 30, 2027. We anticipate that we will have additional sources of liquidity through mortgage financing supported by the guarantee of the United States Department of Agriculture, and equipment lease financing, among other options. However, there are no assurances that these funds will be available. If we are unable to generate sufficient cash flow from operations, control construction costs, or raise additional capital through debt issuances, we may be required to raise additional funds in the form of equity.

 

22

 

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expense, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required because we are a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer, who is also serving as our interim Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Securities and Exchange Act of 1934 Rule 13(a)-15(e). Disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act has been appropriately recorded, processed, summarized, and reported on a timely basis and are effective in ensuring that such information is accumulated and communicated to the Company’s management, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of September 30, 2026, our Chief Executive Officer concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level.

 

Management has identified the following material weakness in our internal control over financial reporting:

 

Management has concluded that there is a material weakness due to the control environment. The control environment is impacted due to the Company’s inadequate segregation of duties, primarily information technology control activities. Our former Chief Financial Officer resigned effective September 1, 2026. While the Company has engaged the services of consultants, the chief financial officer and principal accounting officer positions need to be filled on a permanent basis in order to have better internal controls.

 

Management recognizes that there are inherent limitations in the effectiveness of any system of internal control, and accordingly, even effective internal control can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect material misstatements. In addition, effective internal control at a point in time may become ineffective in future periods because of changes in conditions, such as those that occurred as a result of the business combination, or due to deterioration in the degree of compliance with our established policies and procedures.

 

In an effort to remediate the identified material weakness and enhance our internal control over financial reporting, we will fully engage our information technology personnel to help ensure that we are able to properly implement internal control procedures.

 

This report shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Changes in Internal Control over Financial Reporting

 

None.

 

23

 

 

PART II- OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

As described in Note 5, the Company has an on-going dispute with the Manufacturer, the outcome of which cannot be predicted at this time.

 

From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe a material unfavorable outcome to be remote.

 

Item 1A. Risk Factors.

 

Not required because we are a smaller reporting company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

As of November 9, 2026, Riccardo Delle Coste assumed the position of Interim Principal Accounting Officer, as the Company controller had to step down due to health issues.

 

Item 6. Exhibits.

 

Exhibit No.   Description
     
31.1   Certification of Principal Executive and Financial Officer pursuant to Rule 13a-14(a) (filed herewith)
32.1   Certification pursuant to 18 U.S.C. Section 1350 (furnished herewith)
     
101.INS   Inline XBRL Instance Document*
101.SCH   Inline XBRL Taxonomy Extension Schema Document*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    *XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
     
    In accordance with SEC Release 33-8238, Exhibit 32.1 is furnished and not filed.

 

24

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BARFRESH FOOD GROUP INC.
     
Date: November 16, 2026 By:  /s/ Riccardo Delle Coste
    Riccardo Delle Coste
    Chief Executive Officer
    (Principal Executive Officer and Interim Principal Financial and Accounting Officer)

 

25

 

Keep reading